| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_41b1c8db50aa84c2abd7f1f6d9294bb4 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
| filingDate |
2003-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5afca25156656b2fd5f91ae7ea8fca3b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e81bfd041a467fb6ba863a3283519b7d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d14fc8ca8e86dbb258a9d6ba7e72c7d2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e6adb441cc0b5362233d2f1880c1dc2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1eb1a0d774e3b45bbf4f0c9670e40705 |
| publicationDate |
2004-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
SI-21400-A |
| titleOfInvention |
Stable pharmaceutical formulation with HMG-CoA reductase inhibitor |
| abstract |
The present invention relates to stable pharmaceutical forms comprising active ingredients sensitive to environmental influences and auxiliary pharmaceuticals which allow the stability of one or more active ingredients at the pH of the environment and does not contain any base or buffering agents or combinations thereof. Also described are stable pharmaceutical forms comprising active ingredients sensitive to the pH of the environment, oxidation and / or moisture in the environment, excipients that make the active ingredient resistant to the pH of the environment, and a coating to protect the active ingredient from environmental influences, in particular before oxidation and / or moisture in the environment. Methods for the preparation of stable pharmaceutical forms and the use of such active ingredients for the preparation of pharmaceutical forms for the treatment of dyslipidemias, cardiovascular diseases and other diseases are described. |
| priorityDate |
2003-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |